Susquehanna International Group, LLP Iveric Bio, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$26.24 - $39.63 $1.03 Million - $1.56 Million	-39,400 Reduced 10.16%	348,400 $13.7 Million
Q1 2023 May 16, 2023	BUY	$18.67 - $24.56 $789,741 - $1.04 Million	42,300 Added 12.24%	387,800 $9.44 Million
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $4.7 Million - $6.54 Million	-272,900 Reduced 44.13%	345,500 $7.4 Million
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $179,540 - $355,069	-19,100 Reduced 3.0%	618,400 $11.1 Million
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $1.6 Million - $3.31 Million	175,000 Added 37.84%	637,500 $6.13 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $1.95 Million - $2.7 Million	160,300 Added 53.04%	462,500 $7.78 Million
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $5.06 Million - $6.87 Million	-365,600 Reduced 54.75%	302,200 $5.05 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $3.67 Million - $9.09 Million	519,200 Added 349.39%	667,800 $10.8 Million
Q2 2021 Aug 11, 2021	SELL	$5.69 - $7.17 $1.93 Million - $2.43 Million	-339,000 Reduced 69.52%	148,600 $938,000
Q1 2021 May 17, 2021	BUY	$5.08 - $6.89 $178,816 - $242,528	35,200 Added 7.78%	487,600 $3.01 Million
Q4 2020 Feb 16, 2021	BUY	$5.65 - $7.66 $206,790 - $280,356	36,600 Added 8.8%	452,400 $3.13 Million
Q3 2020 Nov 16, 2020	BUY	$4.01 - $6.29 $1.26 Million - $1.98 Million	314,400 Added 310.06%	415,800 $2.35 Million
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $101,898 - $219,780	33,300 Added 48.9%	101,400 $517,000
Q1 2020 May 15, 2020	SELL	$2.83 - $8.44 $384,597 - $1.15 Million	-135,900 Reduced 66.62%	68,100 $234,000
Q4 2019 Feb 14, 2020	BUY	$0.93 - $8.58 $189,720 - $1.75 Million	204,000 New	204,000 $1.75 Million

Others Institutions Holding ISEE

# of Institutions

Shares Held

250K

Call Options Held

40K

Put Options Held

View Full List

About IVERIC bio, Inc.

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

More about ISEE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account